AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart transplantation is still the gold standard therapy despite emerging treatment options. Due to the limited number of available donors, the use of ventricular assist devices has increased. However, increasing incidences of complications are observed with using these devices. In this article, surgical treatment of a huge mobile thrombus formation in an inflow cannula due to ineffective anticoagulation in a 59year-old man who received a HeartWare ventricular assist device because of ischemic cardiomyopathy is presented
line) infection, arrhythmias and pump thrombosis [4]. The incidence of pump thrombosis was reported ...
There are no reports of acute pump thrombosis in the latest, continuous flow left ventricular assis...
Ventricular assist devices are fast becoming an accepted alternative to treat end-stage heart failur...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative C...
Even if the HeartMate 3TM left ventricular assist device is associated with excellent outcomes, comp...
Thromboembolic events occur in 2–3 % of patients receiving the HeartMate II ™ (HMII) left ventricula...
Left ventricular assist devices are becoming an established treatment for end-stage heart failure. I...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
Long-term mechanical circulatory support is a life-saving technology while briding to heart transpla...
The use of a left ventricular assist device has increased and is a primary surgical treatment for he...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
Extracorporeal and implantable mechanical circulatory support devices are increasingly used for refr...
AbstractBackground: Implantable left ventricular assist devices are common as a bridge to transplant...
line) infection, arrhythmias and pump thrombosis [4]. The incidence of pump thrombosis was reported ...
There are no reports of acute pump thrombosis in the latest, continuous flow left ventricular assis...
Ventricular assist devices are fast becoming an accepted alternative to treat end-stage heart failur...
AbstractHeart failure is one of the leading causes of mortality and morbidity in the world. Heart tr...
Copyright © 2012 Jens Garbade et al. This is an open access article distributed under the Creative C...
Even if the HeartMate 3TM left ventricular assist device is associated with excellent outcomes, comp...
Thromboembolic events occur in 2–3 % of patients receiving the HeartMate II ™ (HMII) left ventricula...
Left ventricular assist devices are becoming an established treatment for end-stage heart failure. I...
PubMed ID: 23622612Background: In this report, we share our experience with left ventricular assist ...
Pump thrombosis is a serious complication of continuous-flow left ventricular assist devices (LVAD)....
Long-term mechanical circulatory support is a life-saving technology while briding to heart transpla...
The use of a left ventricular assist device has increased and is a primary surgical treatment for he...
AbstractThe left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device...
Extracorporeal and implantable mechanical circulatory support devices are increasingly used for refr...
AbstractBackground: Implantable left ventricular assist devices are common as a bridge to transplant...
line) infection, arrhythmias and pump thrombosis [4]. The incidence of pump thrombosis was reported ...
There are no reports of acute pump thrombosis in the latest, continuous flow left ventricular assis...
Ventricular assist devices are fast becoming an accepted alternative to treat end-stage heart failur...